Overview

This bill mandates an independent review into the disablement caused by COVID-19 vaccinations in the UK and the adequacy of the compensation provided. The review will assess the extent of vaccine-related injuries, the effectiveness of monitoring and responses, and the fairness and efficacy of the current compensation system.

Description

The bill requires the Secretary of State to appoint a High Court judge (current or former) to lead an independent review within 30 days of the bill becoming law. This review must assess:

• The rates and extent of disablement caused by each COVID-19 vaccine used in the UK.
• The effectiveness of the Medicines and Healthcare products Regulatory Agency (MHRA) and the NHS and Government's response to monitoring side effects.
• The adequacy of compensation offered, including eligibility criteria, the impact of time limits (under the Limitation Act 1980), and the possibility of a no-fault compensation scheme.
• The efficacy of the Vaccine Damage Payments Act 1979, particularly its 60% disablement threshold.

The review must also assess the costs and benefits of a no-fault compensation scheme, considering its impact on public confidence in vaccination programs. The appointed judge must deliver a report to the Secretary of State within 90 days of their appointment. The Secretary of State will then present this report and the government's response to Parliament within 30 days of receiving it.

Government Spending

The bill does not specify a budget for the independent review. The potential cost will depend on the scope and duration of the review, including potential future compensation costs if the review recommends changes to the existing compensation scheme.

Groups Affected

Groups potentially affected include:

• Individuals who experienced disablement after receiving a COVID-19 vaccination: They may benefit from improved compensation schemes or extended time limits for claims.
• The MHRA, NHS, and Government: Their actions and effectiveness will be subject to review.
• Taxpayers: The cost of the independent review and any subsequent compensation schemes will affect the public purse.
• The public: The review's findings and recommendations could influence public confidence in future vaccination programs.

Powered by nyModel